Papulonecrotic tuberculid.
Palaniappan V, Sadhasivamohan A, Karthikeyan K.
Clin Exp Dermatol. 2022 Oct;47(10):1820-1828. doi: 10.1111/ced.15302. Epub 2022 Aug 3.
Tuberculosis treatment-related lichenoid drug eruptions.
Katran ZY, Bulut I, Babalık A.
Int J Mycobacteriol. 2022 Oct-Dec;11(4):469-471. doi: 10.4103/ijmy.ijmy_151_22.
Drug hypersensitivity in drug-resistant tuberculosis.
Katran ZY, Bulut İ, Babalık A, Keren M, Tepetam FM, Mersin SS, Örçen C, Yakut T, Yavuz D.
World Allergy Organ J. 2023 May 20;16(5):100778. doi: 10.1016/j.waojou.2023.100778. eCollection 2023 May.
Tuberculosis of the oral cavity: an uncommon but still a live issue.
Krawiecka E, Szponar E.
Postepy Dermatol Alergol. 2015 Aug;32(4):302-6. doi: 10.5114/pdia.2014.43284. Epub 2015 Aug 12.
SIDE EFFECTS OF TUBERCULOSIS TREATMENT WITH FIXED-DOSE COMBINATIONS.
Zhang HQ, Xi XE, Wang YL, Han W, Zhang CX, Jiao JH.
J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):379-88.
Recurrent Genital Ulcers.
Bhanja DB, Sil A, Panigrahi A, Biswas SK.
Urology. 2021 Jan;147:33-34. doi: 10.1016/j.urology.2020.10.019. Epub 2020 Oct 24.
Skin tuberculosis in children: learning from India.
Sethuraman G, Ramesh V, Ramam M, Sharma VK.
Dermatol Clin. 2008 Apr;26(2):285-94, vii. doi: 10.1016/j.det.2007.11.006.
Management of adverse reactions to first-line tuberculosis antibiotics.
Nagarajan S, Whitaker P.
Curr Opin Allergy Clin Immunol. 2018 Aug;18(4):333-341. doi: 10.1097/ACI.0000000000000462.
Isoniazid-induced lichenoid eruption reaction.
Kedar AK, Wagh PB.
Pan Afr Med J. 2023 Aug 15;45:162. doi: 10.11604/pamj.2023.45.162.40182. eCollection 2023.
Lichen Scrofulosorum: Cutaneous Manifestation of Tuberculosis.
Rajendiran R, Bolia R, Khuraijam S, Singh A.
J Pediatr. 2021 Dec;239:246-247. doi: 10.1016/j.jpeds.2021.07.040. Epub 2021 Jul 20.
